Povsic, Thomas J.
Scott, Rob
Mahaffey, Kenneth W.
Blaustein, Robert
Edelberg, Jay M.
Lefkowitz, Martin P.
Solomon, Scott D.
Fox, Jonathan C.
Healy, Kevin E.
Khakoo, Aarif Y.
Losordo, Douglas W.
Malik, Fady I.
Monia, Brett P.
Montgomery, Rusty L.
Riesmeyer, Jeffrey
Schwartz, Gregory G.
Zelenkofske, Steven L.
Wu, Joseph C.
Wasserman, Scott M.
Roe, Matthew T.
Funding for this research was provided by:
Duke Clinical Research Institute
Article History
First Online: 22 July 2017
Compliance with Ethical Standards
:
: No outside funding was provided for this work.
: Rob Scott was a former employee of Amgen Inc. and currently employee of AbbVie Pharmaceuticals. Robert Blaustein is an employee of Merck Research laboratories, Merck and Co. Jay Edelberg is an employee of Sanofi US. Martin P. Lefkowtiz is an employee of Novartis Pharmaceuticals. Jonathan <i>C. fox</i> was a former employee of Myokardia Inc. Aarif Y. Khakoo and Scott Wasserman are employees of Amgen Inc. Douglas W. Losordo is am employee of Caladrius Biosciences. Fady I. Malik is an employee of Cytokinetics Inc. Brett P. Monia is an employee Ionis Pharmaceuticals. Rusty Montgomery is an employee of mirage Therapeutics, Inc. Jeffery Riesmeyer is an employee of Eli Lilly, Inc. Steven L. Zelenkofske is an employee of AstraZeneca, Inc. Complete conflicts of interest statements for Drs. Roe and Povsic are available at ExternalRef removed. Complete conflict of interest statements for Dr. Kenneth W. Mahaffey and Joseph C. Wu is available at ExternalRef removed. Dr. Gregory G. Schwartz, through his institution, has received research support from Cerenis, The Medicines Company, Resverlogix, Roche, and Sanofi. Dr. Healy reports no conflicts of interest.
: The manuscript does not describe new research involving human participants or animals and did not require separate ethical approval.
: The manuscript does not describe new research requiring informed consent.